[³H]-SR 27897B: A Selective Probe for Autoradiographic Labelling of CCK-A Receptors in the Brain

References

• Williams J. ZA. Cholecystokinin: a hormone and a neurotransmitter. Biomed Res. 1982; 3: 107–121
   Google Scholar
• Vanderhaeghen J.-J., Signeau J. C., Gepts W. New peptide in vertebrate CNS reacting with antigastrin antibodies. Nature 1975; 257: 604–605
   PubMed Web of Science ®Google Scholar
• Van der haeghen J.-J., Lotstra F., De Mey J., Gilkes C. Immunohistochemical localization of cholecystokinin-and gastrin-like peptides in the brain and hypophysis of the rat. Proc. Natl. Acad. Sci. USA 1980; 7: 1190–1194
   Google Scholar
• Dockray G. J. Immunochemical evidence of cholecystokinin-like peptides in brain. Nature 1976; 264: 568–570
   PubMed Web of Science ®Google Scholar
• Innis R. B., Correra F. M. A., Uhl G. R., Screider B., Snyder S. H. Cholecystokinin octapeptide-like immunoreactivity: histochemical localization in rat brain. Proc. Natl. Acad. Sci. USA 1979; 76: 521–525
   PubMed Web of Science ®Google Scholar
• Silver A. F., Flood J. F., Song A. M., Morley J. E. Evidence for a physiological role of CCK in the regulation of food intake in mice. Am. J. Physiol. 1989; 256: R646–652
   PubMed Web of Science ®Google Scholar
• Reidelberger R. D., Kalogeris T. J., Solomon T. E. Plasma CCK levels after food intake and infusion of CCK analogues that inhibit feeding in dogs. Am. J. Physiol. 1989; 256: R1148–1154
   Google Scholar
• Innis R. B., Snyder S. H. Distinct cholecystokinin receptors in brain and pancreas. Proc. Natl. Acad. Sci. USA 1980; 77: 6917–6921
   PubMed Web of Science ®Google Scholar
• Wank S. A., Harkins R., Jensen R. T., Shapira H., DeWeerth A., Slattery T. Purification, molecular cloning and functional expression of the cholecystokinin receptors from rat pancreas. Proc. Natl. Acad. Sci. USA 1992; 89: 3125–3129
   PubMed Web of Science ®Google Scholar
• Grider J. R., Makhlouf G. M. Regional and cellular heterogeneity of cholecystokinin receptors mediating muscle contraction in the gut. Gastroenterology 1987; 92: 175–180
   PubMedGoogle Scholar
• Liddle R. A., Green G. M., Conrad C. K., Williams J. A. Effect of a novel cholecystokinin receptor antagonist, MK329 on gall-bladder contraction and gastric emptying in humans. J. Clin. Invest 1989; 84: 1220–1225
   PubMed Web of Science ®Google Scholar
• Shaw M. J., Hadac E. M., Miller L. J. Preparation of enriched plasma membranes from bovine gall bladder muscularis for characterization of cholecystokinin receptors. J. Biol. Chem. 1987; 262: 14313–14318
   PubMed Web of Science ®Google Scholar
• Hill R. G., Hughes J., Pittaway K. M. Antinociceptive action of cholecystokinin octapeptide (CCK8) and related peptides in rats and mice; Effects of naloxone and peptidase inhibitors. Neuropharmacol. 1987; 26: 289–300
   PubMed Web of Science ®Google Scholar
• Hewson G., Leighton G. E., Hill R. G., Hughes J. The cholecystokinin receptor antagonist L-374,718 increases food intake in the rat by attenuating of the action of endogenous cholecystokinin. Br. J. Pharmacol. 1988; 93: 79–84
   PubMedGoogle Scholar
• Paris P. L., Komisaruk B. R., Watkins L. R., Mayer D. J. Evidence for the neuropeptide cholecystokinin as an antagonist of opiate analgesia. Science 1983; 219: 310–312
   Google Scholar
• Wieterlak E. P., Maier S. F., Watkins L. R. Cholecystokinin antianalgesia: safety cues abolish morphine analgesia. Science 1992; 256: 830–833
   Google Scholar
• Moran T. H., Robinson P., Goldrich M. S., McHugh P. Two brain cholecystokinin receptors: Implications for behavioural actions. Brain Res. 1986; 362: 175–179
   PubMed Web of Science ®Google Scholar
• Chang R. S.L., Lotti V. J., Chen T. B., Keegan M. E. Tifluadom; a -opiate agonist, acts as a peripheral cholecystokinin receptor antagonist. Neurosci. Lett. 1986; 72: 211–214
   PubMed Web of Science ®Google Scholar
• Chang R. S. L., Lotti V. J. Biochemical and pharmacological characterization of an extremely potent and selective non-peptide cholecystokinin antagonist. Proc. Natl. Acad. Sci. USA 1986; 83: 4923–4926
   PubMed Web of Science ®Google Scholar
• Hill D. R., Campbell N. J., Show T. M., Woodruff G. N. Autoradiographic localization and biochemical characterization of peripheral type CCK receptors in rat CNS using highly selective nonpeptide CCK antagonists. J. Neuroscience 1987; 7: 2967–2976
   PubMed Web of Science ®Google Scholar
• Hill D. R., Shaw T. M., Graham W., Woodruff G. N. Autoradiographical detection of cholecystokinin-A receptors in primate brain using 125Bolton Hunter CCK8 and 3H-MK-329. J. Neuroscience 1990; 10: 1070–1081
   PubMed Web of Science ®Google Scholar
• Gully D., Fréhel D., Marcy C., Spinazzé A., Lespy L., Neliat G., Maffrand J.-P., Le Fur G. Peripheral biological activity of SR27897B: a new potent non-peptide anatgonist of CCKA receptors. Eur. J. Pharmacol 1993; 232: 13–19
   PubMed Web of Science ®Google Scholar
• Poncelet M., Arnone M., Heaulme M., Gonalons N., Gueudet C., Santucci V., Thurneyssen O., Keane P., Gully D., LeFur G., Subrié P. Neurobehavioural effects of SR27897B, a selective cholecystokinin type A (CCK-A) receptor antagonist. Naunyn-Schmiedeberg's Arch. Pharmacol. 1993; 348: 102–107
   Google Scholar
• Kuhar M. J., Unnerstall J. R. Quantitative receptor mapping by autoradiography: some current technical problems. Trends Neurosci. 1985; 49–53
   Google Scholar
• Paxinos G., Watson C. The rat brain in stereotaxic coordinates. Academic Press, New-York 1982
   Google Scholar
• Denauvit-Saubié M., Hurle M., Morin-Satin P., Foutz A. S., Champagnat J. The effects of cholecystokinin-8 in the nucleus tractus solitarius. Ann. NY Acad. Sci. 1985; 448: 375–384
   Google Scholar
• Morin M. P., DeMarchi P., Champagnat J., Vanderhaeghen J. J., Rossier J., Denauvit-Saubié M. Inhibitory effects of cholecystokinin octapeptide on neurons in the nucleus tractus solitarius. Brain Res. 1983; 265: 333–338
   PubMed Web of Science ®Google Scholar
• Miaskiewicz S. L., Stricker E. M., Verbalis J. G. Neurohypophyseal secretion in response to cholecystokinin but not meal-induced gastric distension in humans. J. Clin. Endocr. Metab. 1989; 68: 837–843
   Google Scholar
• Parrott R. F., Forsling M.L. The CCKA receptor antagonist devazepide inhibits the effect of apomorphine on vasopressin release in pigs. Gen. Pharmac. 1994; 25: 1337–1340
   Google Scholar
• Wislocki G. B., Putnam T. J. Note on the anatomy of the area postrema. Anat. Rec. 1920; 19: 281–287
   Google Scholar
• Worms P., Gueudet C., Biziére K. Induction of turning by direct intrastriatal injection of dopaminomimetic drugs in mice: pharmacological analysis of a simple screening model. Life Sci. 1986; 39: 2199–2208
   Google Scholar